Although the genomic landscape of NPC has recently been defined, disappointingly only a subset of NPC cases (>10%) was found to harbor immediately druggable somatic events, such as alterations of PIK3CA, FGFR3, and JAK1/2 (3, 15, 16). Here, JAK1 is linked to nasopharyngeal carcinoma.